As of Dec 13
| +0.12 / +0.06%|
The 8 analysts offering 12-month price forecasts for Abiomed Inc have a median target of 197.50, with a high estimate of 208.00 and a low estimate of 186.00. The median estimate represents a +2.30% increase from the last price of 193.06.
The current consensus among 11 polled investment analysts is to Buy stock in Abiomed Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.